Abstract
Background/Objectives:
This study aims to increase knowledge regarding the association of sarcopenia with hospitalization costs among a wide-ranging sample of adult hospitalized patients.
Subjects/Methods:
A prospective study was conducted among hospitalized adult patients. Sarcopenia was identified according to the European Working Group on Sarcopenia in Older People, as low muscle mass, assessed by bioelectrical impedance analysis and low muscle function evaluated by handgrip strength. Hospitalization cost was calculated for each patient based on discharge diagnosis-related group codes and determined on the basis of a relative weight value. Costs were defined as the percentage of deviation from the cost of a patient with a relative weight equal to one. Multivariable linear regression models were performed to identify the factors independently associated with hospitalization costs.
Results:
A total of 656 hospitalized patients aged ⩾18 years (24.2% sarcopenic) composed the study sample. Sarcopenia increased hospitalization costs by €1240 (95% confidence interval (CI): €596–1887) for patients aged <65 years and €721 (95% CI: €13–1429) for patients aged ⩾65 years. Sarcopenic overweight was related to an increase in hospitalization costs of €884 (95% CI: €295–1476).
Conclusions:
Sarcopenia is independently related to hospitalization costs. This condition is estimated to increase hospitalization costs by 58.5% for patients aged <65 years and 34% for patients aged ⩾65 years.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412–423.
Janssen I, Heymsfield SB, Ross R . Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889–896.
Abellan van Kan G . Epidemiology and consequences of sarcopenia. J Nutr Health Aging 2009; 13: 708–712.
Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2014; 69: 438–446.
Cherin P, Voronska E, Fraoucene N, de Jaeger C . Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years. Aging Clin Exp Res 2014; 26: 137–146.
Gariballa S, Alessa A . Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr 2013; 32: 772–776.
Smoliner C, Sieber CC, Wirth R . Prevalence of sarcopenia in geriatric hospitalized patients. J Am Med Dir Assoc 2014; 15: 267–272.
Cerri AP, Bellelli G, Mazzone A, Pittella F, Landi F, Zambon A et al. Sarcopenia and malnutrition in acutely ill hospitalized elderly: prevalence and outcomes. Clin Nutr 2015; 34: 745–751.
Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF . Sarcopenia among hospitalized patients - a cross-sectional study. Clin Nutr 2015; 34: 1239–1244.
Rossi AP, Fantin F, Micciolo R, Bertocchi M, Bertassello P, Zanandrea V et al. Identifying sarcopenia in acute care setting patients. J Am Med Dir Assoc 2014; 15: 303 e7–303 12.
Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Capoluongo E et al. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 2012; 31: 652–658.
Otsuji H, Yokoyama Y, Ebata T, Igami T, Sugawara G, Mizuno T et al. Preoperative sarcopenia negatively impacts postoperative outcomes following major hepatectomy with extrahepatic bile duct resection. World J Surg 2015; 39: 1494–1500.
Joglekar S, Asghar A, Mott SL, Johnson BE, Button AM, Clark E et al. Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol 2014; 111: 771–775.
Du Y, Karvellas CJ, Baracos V, Williams DC, Khadaroo RG . Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 2014; 156: 521–527.
Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE . Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012; 107: 931–936.
Vetrano DL, Landi F, Volpato S, Corsonello A, Meloni E, Bernabei R et al. Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. J Gerontol A Biol Sci Med Sci 2014; 69: 1154–1161.
Thomas DR . Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 2007; 26: 389–399.
Beaudart C, Rizzoli R, Bruyere O, Reginster JY, Biver E . Sarcopenia: burden and challenges for public health. Arch Public Health 2014; 72: 45.
Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R . The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004; 52: 80–85.
Sheetz KH, Waits SA, Terjimanian MN, Sullivan J, Campbell DA, Wang SC et al. Cost of major surgery in the sarcopenic patient. J Am Coll Surg 2013; 217: 813–818.
Friedman J, Lussiez A, Sullivan J, Wang S, Englesbe M . Implications of sarcopenia in major surgery. Nutr Clin Pract 2015; 30: 175–179.
Kirk PS, Friedman JF, Cron DC, Terjimanian MN, Wang SC, Campbell DA et al. One-year postoperative resource utilization in sarcopenic patients. J Surg Res 2015; 30: 074.
ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr 2002; 26 (1 Suppl), 1SA–138SA.
Hodkinson HM . Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1972; 1: 233–238.
Katz S . Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983; 31: 721–727.
Charlson ME, Pompei P, Ales KL, MacKenzie CR . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383.
Ottery F . Patient-generated subjective global assessment. In: McCallum P, Polisena C. (eds). The Clinical Guide to Oncology Nutrition. The American Dietetic Association: Chicago, IL, USA, 2000, pp 11–23.
Marfell-Jones M, Olds T, Stewart A, Carter L . International Standards for Anthropometric Assessement. ISAK: Potchefstroom, South Africa, 2006.
Janssen I, Heymsfield SB, Baumgartner RN, Ross R . Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000; 89: 465–471.
Fess E . Grip strength. In: Casanova J (ed) Clinical Assessment Recommendations. American Society of Hand Therapists: Chicago, IL, USA, 1992, pp 41–45.
Vaz M, Thangam S, Prabhu A, Shetty PS . Maximal voluntary contraction as a functional indicator of adult chronic undernutrition. Br J Nutr 1996; 76: 9–15.
Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995; 854: 1–452.
Portaria n.º 839- A/2009. Diário da República. Portugal, 2009.
Portaria n.º 163/2013. Diário da República. Portugal, 2013.
Portaria nº 20/2014. Diário da República. Portugal, 2014.
Direção-Geral da Saúde. Direção de Serviços de Informação e Análise/Divisão de Estatísticas da Saúde e Monitorização. Centros de Saúde e Unidades Hospitalares. Recursos e Produção. Portugal, 2012.
Guerra RS, Amaral TF, Sousa AS, Pichel F, Restivo MT, Ferreira S et al. Handgrip strength measurement as a predictor of hospitalization costs. Eur J Clin Nutr 2015; 69: 187–192.
Freijer K, Tan SS, Koopmanschap MA, Meijers JM, Halfens RJ, Nuijten MJ . The economic costs of disease related malnutrition. Clin Nutr 2013; 32: 136–141.
Acknowledgements
We thank Centro Hospitalar do Porto and all ward directors for facilitating the data collection. RSG received a scholarship from Fundação para a Ciência e a Tecnologia, financing program POPH/FSE, under the project SFRH/BD/61656/2009.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Sousa, A., Guerra, R., Fonseca, I. et al. Financial impact of sarcopenia on hospitalization costs. Eur J Clin Nutr 70, 1046–1051 (2016). https://doi.org/10.1038/ejcn.2016.73
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2016.73
This article is cited by
-
Cost-effectiveness analysis of sarcopenia management interventions in Iran
BMC Public Health (2023)
-
Spectrochemical analysis of blood combined with chemometric techniques for detecting osteosarcopenia
Scientific Reports (2023)
-
Handgrip strength conditional tolerance regions suggest the need for personalized sarcopenia definition: an analysis of the American NHANES database
Aging Clinical and Experimental Research (2023)
-
Prevalence of sarcopenia in community dwelling outpatient postmenopausal Hungarian women
BMC Musculoskeletal Disorders (2022)
-
Association between oral intake magnesium and sarcopenia: a cross-sectional study
BMC Geriatrics (2022)